Literature DB >> 8563720

Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration.

G Aguilera1, A Kiss, X Luo.   

Abstract

Double staining in situ hybridization studies have shown that angiotensin II (AII) type 1 receptors (AT1) in the hypothalamic paraventricular nucleus (PVN) are located primarily in corticotropin releasing hormone (CRH) neurons of the parvicellular subdivision. The purpose of these studies was to investigate the role of AII regulating the hypothalamic-pituitary adrenal (HPA) axis, by correlating AT1 receptor expression levels in the PVN with the known changes in activity of the HPA axis under different stress paradigms, and manipulation of circulating glucocorticoids. AT1 receptor mRNA was measured by in situ hybridization using 35S-labelled cRNA probes and AII binding by autoradiography using 125I[Sar1,Ile8]AII in slide mounted hypothalamic sections. AT1 receptor mRNA levels and AII binding in the PVN were reduced by about 20% 18 h after adrenalectomy remaining at these levels up to 6 days after. This effect was prevented by corticosterone administration in the drinking water, or dexamethasone injection (100 mg, s.c., daily). Conversely, dexamethasone injection in intact rats caused a 20% increase in AT1 receptor mRNA in the PVN. AT1 receptor mRNA and binding in the PVN increased 4 h after exposure to stress paradigms associated with activation of the HPA axis (immobilization for 1 h, or i.p. injection of 1.5 M NaCl), and remained elevated after repeated daily stress for 14 days. Unexpectedly, two osmotic stress models associated with inhibition of the HPA axis (60 h water deprivation or 12 days of 2% saline intake) also resulted in increased AT1 receptor mRNA levels and AII binding in the parvicellular PVN. In intact rats, the stimulatory effect of acute stress on AT1 receptor mRNA in the PVN was significantly enhanced by dexamethasone administration (100 micrograms, s.c., 14 h and 1 h prior to stress), while in adrenalectomized rats, with or without glucocorticoid replacement, stress reduced rather than increased, AT1 receptor mRNA. Dexamethasone, 100 micrograms, injected sc within 1 min the beginning of immobilization in adrenalectomized rats, increased AT1 receptor mRNA in the PVN to levels significantly higher than those after dexamethasone alone, indicating that the stress induced glucocorticoid surge is required for the stimulatory effect of stress on AT1 receptor mRNA. The data suggest that AT1 receptor expression in the PVN is under dual control during stress: stress-activated inhibitory pathways and the stimulatory effect of glucocorticoids. The lack of specificity of the changes in AT1 receptor expression in the PVN following stressors with opposite effects on ACTH secretion (osmotic and physical-psychological stress) does not support a role for AII as a major determinant of the response of the HPA axis during stress.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563720     DOI: 10.1111/j.1365-2826.1995.tb00714.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  29 in total

1.  Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

Authors:  Anja Miesel; Helge Müller-Fielitz; Olaf Jöhren; Florian M Vogt; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Effects of losartan on catecholamine release in the isolated rat adrenal gland.

Authors:  Hae-Jeong Noh; Yoon-Sung Kang; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

3.  Genetic variants in the renin-angiotensin system and blood pressure reactions to the cold pressor test.

Authors:  Laiyuan Wang; Liping Hou; Hongfan Li; Jing Chen; Tanika N Kelly; Cashell E Jaquish; Dabeeru C Rao; James E Hixson; Dongsheng Hu; Chung-Shiuan Chen; Charles Gu; Shufeng Chen; Xiangfeng Lu; Paul K Whelton; Jiang He; Fanghong Lu; Jianfeng Huang; De-Pei Liu; Dongfeng Gu
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

4.  Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptors.

Authors:  Nan Jiang; Peng Shi; Hongwei Li; Shun Lu; Leah Braseth; Adolfo E Cuadra; Mohan K Raizada; Colin Sumners
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

5.  Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.

Authors:  Anil Kumar; Barinder Singh; Jitendriya Mishra; Sangeeta Pilkhwal Sah; Raghavender Pottabathini
Journal:  Inflammopharmacology       Date:  2015-06-30       Impact factor: 4.473

Review 6.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 7.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Age-dependent alterations to paraventricular nucleus insulin-like growth factor 1 receptor as a possible link between sympathoexcitation and inflammation.

Authors:  Olalekan M Ogundele; Charles C Lee; Joseph Francis
Journal:  J Neurochem       Date:  2016-10-19       Impact factor: 5.372

9.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice.

Authors:  Lei Wang; Helmut Hiller; Justin A Smith; Annette D de Kloet; Eric G Krause
Journal:  Physiol Genomics       Date:  2016-07-28       Impact factor: 3.107

10.  Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear.

Authors:  R C Hurt; J C Garrett; O P Keifer; A Linares; L Couling; R C Speth; K J Ressler; P J Marvar
Journal:  Genes Brain Behav       Date:  2015-08-25       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.